Stage 1 Hodgkin’s Lymphoma is found in either one lymph node or one lymphoid organ. Stage 2 Hodgkin’s Lymphoma is found in two or more lymph nodes. Stage 3 Hodgkin’s Lymphoma is found in areas superior and inferior to the diaphragm. And finally, Stage 4 Hodgkin’s Lymphoma can be found in various organs and areas outside of the lymphatic system. Treating Hodgkin’s Lymphoma can come in various options; however, two options are the most common. Radiation therapy is the exposure to X-rays and is used more commonly for Stage 1 Hodgkin’s Lymphoma. The exposed X-rays are concentrated on lymphoma cells, killing them. Chemotherapy is treatment with toxic drugs or chemicals to kill the lymphoma cells. Chemotherapy is usually used in accordance to radiation therapy, not always killing the lymphoma cells; however, destroying them and making them weak so the radiation X-rays can completely kill the cells. The effectiveness for chemo and radiation therapy can vary based on new advances in technology and treatments. In a clinical trial of 405 patients with Stage 1 and Stage 2 Hodgkin’s Lymphoma, the survival rate for those treated with chemotherapy was 94% and the survival rate for those treated with radiation therapy was 87%. In result, the effectiveness of treatment for Hodgkin’s Lymphoma whether it be chemotherapy or radiation therapy (or both), is very
Stage 1 Hodgkin’s Lymphoma is found in either one lymph node or one lymphoid organ. Stage 2 Hodgkin’s Lymphoma is found in two or more lymph nodes. Stage 3 Hodgkin’s Lymphoma is found in areas superior and inferior to the diaphragm. And finally, Stage 4 Hodgkin’s Lymphoma can be found in various organs and areas outside of the lymphatic system. Treating Hodgkin’s Lymphoma can come in various options; however, two options are the most common. Radiation therapy is the exposure to X-rays and is used more commonly for Stage 1 Hodgkin’s Lymphoma. The exposed X-rays are concentrated on lymphoma cells, killing them. Chemotherapy is treatment with toxic drugs or chemicals to kill the lymphoma cells. Chemotherapy is usually used in accordance to radiation therapy, not always killing the lymphoma cells; however, destroying them and making them weak so the radiation X-rays can completely kill the cells. The effectiveness for chemo and radiation therapy can vary based on new advances in technology and treatments. In a clinical trial of 405 patients with Stage 1 and Stage 2 Hodgkin’s Lymphoma, the survival rate for those treated with chemotherapy was 94% and the survival rate for those treated with radiation therapy was 87%. In result, the effectiveness of treatment for Hodgkin’s Lymphoma whether it be chemotherapy or radiation therapy (or both), is very